Why Unilever Stock Could Keep Rising: Bullish Drivers Ahead

01. Historical Context

The stock can still rise because the operating base is improving

Unilever's Q1 2026 numbers matter more than any slogan. Turnover was EUR12.6 billion, underlying sales growth was 3.8%, and volume rose 2.9%. That is the sort of mix that can support a higher share price because it shows the company is still getting real demand, not just price carry.

Editorial scenario visual for Unilever — Unilever's upside case is rooted in steady volume, productivity, and capital returns rather than in a dramatic rerating.

Near-term framework for Unilever

Horizon	What matters most	What would strengthen the thesis	What would weaken the thesis
1-3 months	Whether Q2 confirms Q1 volume	Another quarter of positive volume and stable mix	Growth slipping below the guidance floor
6-12 months	EPS and free-cash-flow conversion	Consensus estimates hold or rise	Margin pressure or weaker cash conversion
To 2027	Shareholder returns	Buybacks and productivity keep lifting per-share earnings	Capital returns slow or portfolio costs absorb gains

The reason the upside is not purely speculative is that Unilever also ended 2025 with a 20.0% underlying operating margin and EUR5.9 billion of free cash flow. That gives the company enough financial room to keep rewarding shareholders while it executes.

02. Key Forces

Five bullish forces that could extend the move

First, current valuation still leaves room for gains. UL traded at 11.15x trailing earnings and 15.12x forward earnings on May 15, 2026. For a defensive business with improving volume, that is not a stretched setup.

Second, the earnings bridge is still constructive. MarketScreener's estimate path of EUR3.03 EPS for 2026 and EUR3.261 for 2027 implies that analysts still see meaningful per-share growth ahead.

Third, productivity is arriving. Unilever said it had already delivered EUR750 million of the EUR800 million savings target due by the end of 2026. That strengthens the case for margin support even if the macro backdrop stays mixed.

Fourth, buybacks are real. The EUR1.5 billion repurchase already launched, plus the disclosed potential for up to EUR6 billion of buybacks through 2029, make the upside case more tangible because they improve per-share math even without an aggressive sales acceleration.

Fifth, the macro backdrop is soft but not recessionary. IMF global growth forecasts of 3.1% for 2026 and 3.2% for 2027 are good enough for a staples compounder if inflation does not worsen materially.

Bullish factor scorecard for Unilever

Factor	Current Assessment	Bias	Why it matters now
Volume trend	Q1 2026 volume up 2.9%	Bullish	Positive volume is the strongest confirmation of a healthy advance
EPS path	Consensus still points higher into 2027	Bullish	The stock can rerate modestly if estimates remain intact
Productivity	EUR750 million of savings already delivered	Bullish	Supports margins and confidence in execution
Capital return	Buybacks are active and potentially large through 2029	Bullish	Strengthens the per-share compounding case
Macro backdrop	Growth remains positive, inflation remains sticky	Neutral	Good enough for upside, but not good enough to ignore rates

Taken together, those factors support a constructive stance. The stock does not need a new narrative. It needs more quarters that look like Q1 2026.

03. Countercase

What could interrupt the rally

The main risk is still rates. U.S. CPI was 3.8% in April 2026, first-quarter PCE inflation was 4.5%, core PCE was 4.3%, and euro-area inflation was 3.0%. If that inflation profile lingers, the multiple can stall even if operations are decent.

The second risk is a growth disappointment against management's own 4% to 6% sales-growth guide. A stock with a credible bullish case can still fall if the next two updates fail to confirm the current pace.

The third risk is execution around portfolio simplification and stranded costs. That does not invalidate the long-term case, but it can slow the near-term rerating.

What could derail the bullish setup

Risk	Latest data point	Current Assessment	Bias
Sticky inflation	CPI and PCE are still elevated	Still the biggest multiple headwind	Bearish
Guide miss	Q1 growth was 3.8% versus a 4% to 6% full-year guide	Needs stronger follow-through	Neutral
Execution drag	Portfolio changes bring stranded-cost and restructuring risks	Manageable, but worth watching	Neutral

The bullish case remains valid only while the operating evidence keeps improving faster than these risks worsen.

04. Institutional Lens

Sell-side inputs are constructive, but not euphoric

MarketBeat's current ADR target average of $65.55, with a $60.10 low and $71.00 high, frames a realistic bullish corridor for the next 12 months. MarketScreener's 2026 and 2027 EPS estimates on the European line also support an orderly advance rather than an explosive rerating.

Macro research is consistent with that view. IMF forecasts still show positive global growth, while J.P. Morgan Asset Management warns that corrections can still happen even in a decent macro backdrop. That combination is exactly the kind of environment in which Unilever can outperform without looking dramatic.

Institutional markers for the bull case

Source	Updated	What it says	Why it matters here
MarketBeat	May 2026	Average ADR target $65.55; high $71.00	Shows the market still sees incremental upside
MarketScreener	May 2026	2026 EPS EUR3.03; 2027 EPS EUR3.261	Supports the earnings-led bull case
IMF WEO	April 14, 2026	Global growth remains positive through 2027	Helps the demand side stay orderly
J.P. Morgan AM	2026 outlook	Growth may moderate, but volatility remains possible	Upside should be expected to come with resets

The institutional lens therefore supports further upside, but it supports it as a disciplined grind rather than as a one-way move.

05. Scenarios

How to think about buying, holding, or trimming from here

12-month scenario map for Unilever

Scenario	Probability	Trigger	Target range	Review point
Bull	40%	Volume stays above 2%, guidance holds, and analysts keep the 2027 EPS path intact	$63 to $71	Review after the July 2026 half-year update and November 4, 2026 Capital Markets Day
Base	35%	Execution stays decent, but inflation caps valuation expansion	$57 to $62	Reassess after FY2026 results
Bear	25%	Growth slows below guidance or the market derates staples multiples	$48 to $55	Review if volume drops below the 2% guide floor

The highest-quality bullish setup is one in which results keep doing the work. If price rises while volume, EPS, and buybacks all stay supportive, the rally remains investable.

References